AD,RAD2025,AtopicDermatitis,DermTwitter

Mashup Score: 0

Weighing In on Biologics and JAK Inhibitors for Atopic Dermatitis - 4 day(s) ago

Christopher Bunick, MD, PhD, discusses key differences in AD biologics and challenges in achieving optimal treatment targets.

Source: www.dermatologytimes.com

Categories: General Medicine News, Dermatology

Tweet Tweets with this article
- DermTimesNow
  
  💡 New insights from Christopher Bunick, MD, PhD, highlight how IL-13/ IL-31-targeting biologics and JAK inhibitors offer diverse paths to itch relief and clearance in #AD. https://t.co/Zn31GFEoYe Register for #RAD2025: https://t.co/0oLavFICMj #AtopicDermatitis #DermTwitter